Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

2019-03-08 14:07 by SMOC

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property. The license is subject to a research use limited label. 

Under the term of the agreement, SMOC will combine the Broad's CRISPR-Cas9 technology with its own high-throughput production capacity, to enable the development of customized animal models in a unprecedentedly fast and cost-efficient manner. 

Related Articles


Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

Learn More
Contact us Email Gene-editing proposal Gene-editing proposal Back to top Back to top